Literature DB >> 4152919

Influence of the alternate complement pathway in opsonization of several bacterial species.

A Forsgren, P G Quie.   

Abstract

In normal human serum chelated with magnesium (10 mM) and ethylene glycotetraacetic acid (10 mM) (MgEGTA), the classical pathway of complement activation is blocked; however, the alternate pathway of complement activation is intact. Diplococcus pneumoniae, Staphylococcus albus, Streptococcus viridans, Streptococcus faecalis, and Serratia marcescens were opsonized in normal human serum containing 10 mM MgEGTA. In contrast, Staphylococcus aureus and Pseudomonas aeruginosa were poorly opsonized in human serum chelated with 10 mM MgEDTA. Therefore certain bacterial species appear to require the classical pathway of complement activation to be opsonized and other bacterial species utilize the alternate pathway of complement activation.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4152919      PMCID: PMC415013          DOI: 10.1128/iai.10.2.402-404.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.

Authors:  A Forsgren; P G Quie
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

3.  Opsonic activity in human serum deficient in C2.

Authors:  F R Johnson; V Agnello; R C Williams
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

4.  Opsonic activity of agammaglobulinemic human sera.

Authors:  R C Williams; P G Quie
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

5.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.

Authors:  H E Jasin
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

  6 in total
  36 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  A novel method for direct measurement of complement convertases activity in human serum.

Authors:  A M Blom; E B Volokhina; V Fransson; P Strömberg; L Berghard; M Viktorelius; T E Mollnes; M López-Trascasa; L P van den Heuvel; T H Goodship; K J Marchbank; M Okroj
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

3.  Evidence for quantitative variability of bacterial opsonic requirements.

Authors:  J C Guckian; W D Christensen; D P Fine
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.

Authors:  G Füst; L Bertók; S Juhász-Nagy
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

Review 5.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

6.  Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors.

Authors:  R J Weinstein; L S Young
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

7.  Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.

Authors:  W H Traub; I Kleber
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

9.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

10.  Contribution of immunoglobulins M and G, complement, and properdin to the intracellular killing of Escherichia coli by polymorphonuclear leukocytes.

Authors:  J Menzel; H Jungfer; D Gemsa
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.